Cite
HARVARD Citation
Tomaszewska-Kiecana, M. et al. (2023). Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults. Expert review of clinical immunology. pp. 439-446. [Online].